Fresenius Medical Care AG KGaA Free Cash Flow 2010-2024 | FMS
Fresenius Medical Care AG KGaA annual/quarterly free cash flow history and growth rate from 2010 to 2024. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
- Fresenius Medical Care AG KGaA free cash flow for the quarter ending June 30, 2024 was 309.21, a year-over-year.
- Fresenius Medical Care AG KGaA free cash flow for the twelve months ending June 30, 2024 was , a year-over-year.
- Fresenius Medical Care AG KGaA annual free cash flow for 2023 was $2.122B, a 36.1% increase from 2022.
- Fresenius Medical Care AG KGaA annual free cash flow for 2022 was $1.559B, a 20.6% decline from 2021.
- Fresenius Medical Care AG KGaA annual free cash flow for 2021 was $1.963B, a 46.23% decline from 2020.
| Fresenius Medical Care AG KGaA Annual Free Cash Flow | |
|---|---|
| 2023 | 2,121.68 |
| 2022 | 1,558.90 |
| 2021 | 1,963.43 |
| 2020 | 3,651.65 |
| 2019 | 1,628.14 |
| 2018 | 1,250.87 |
| 2017 | 1,526.56 |
| 2016 | 1,127.55 |
| 2015 | 1,024.51 |
| 2014 | 941.44 |
| 2013 | 1,306.71 |
| 2012 | 1,373.42 |
| 2011 | 876.00 |
| 2010 | 860.60 |
| 2009 | 776.74 |
| Fresenius Medical Care AG KGaA Quarterly Free Cash Flow | |
|---|---|
| 2024-06-30 | 309.21 |
| 2024-03-31 | -2.37 |
| 2023-12-31 | 2,121.68 |
| 2023-09-30 | 1,610.99 |
| 2023-06-30 | 931.36 |
| 2023-03-31 | 2.51 |
| 2022-12-31 | 1,558.90 |
| 2022-09-30 | 1,089.71 |
| 2022-06-30 | 618.27 |
| 2022-03-31 | -1.30 |
| 2021-12-31 | 1,963.43 |
| 2021-09-30 | 1,484.87 |
| 2021-06-30 | 901.98 |
| 2021-03-31 | 34.63 |
| 2020-12-31 | 3,651.65 |
| 2020-09-30 | 3,405.87 |
| 2020-06-30 | 2,650.01 |
| 2020-03-31 | 334.86 |
| 2019-12-31 | 1,628.14 |
| 2019-09-30 | 1,133.53 |
| 2019-06-30 | 489.24 |
| 2019-03-31 | -140.13 |
| 2018-12-31 | 1,250.87 |
| 2018-09-30 | 602.05 |
| 2018-06-30 | 197.21 |
| 2018-03-31 | -323.52 |
| 2017-12-31 | 1,526.56 |
| 2017-09-30 | 1,233.84 |
| 2017-06-30 | 730.81 |
| 2017-03-31 | -27.15 |
| 2016-12-31 | 1,127.55 |
| 2016-09-30 | 562.26 |
| 2016-06-30 | 359.46 |
| 2016-03-31 | -66.46 |
| 2015-12-31 | 1,024.51 |
| 2015-09-30 | 775.54 |
| 2015-06-30 | 421.01 |
| 2015-03-31 | 249.65 |
| 2014-12-31 | 941.44 |
| 2014-09-30 | 635.08 |
| 2014-06-30 | 146.64 |
| 2014-03-31 | -84.86 |
| 2013-12-31 | 1,306.71 |
| 2013-09-30 | 952.13 |
| 2013-06-30 | 521.69 |
| 2013-03-31 | 169.38 |
| 2012-12-31 | 1,373.42 |
| 2012-09-30 | 1,028.70 |
| 2012-06-30 | 658.21 |
| 2012-03-31 | 358.61 |
| 2011-12-31 | 876.00 |
| 2011-09-30 | 569.59 |
| 2011-06-30 | 256.00 |
| 2011-03-31 | 237.00 |
| 2010-12-31 | 860.60 |
| 2010-09-30 | 687.67 |
| 2010-06-30 | 425.41 |
| 2010-03-31 | 250.04 |
| 2009-12-31 | 776.74 |
| 2009-09-30 | 492.12 |
| 2009-06-30 | 187.77 |
| 2009-03-31 | 44.86 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $12.447B | $21.053B |
| Fresenius Medical Care AG & Co. KGaA is one of the largest integrated providers of products and services for individuals undergoing dialysis. Fresenius Medical provides products and services across the entire dialysis value chain throughout the World. Fresenius Medical manufactures a variety of durable medical devices used in the treatment of End Stage Renal Disease (ESRD). Devices like Hemodialysis Machines, Peritoneal Dialysis Machines, Granuflo Concentrate Mixing Tanks and monitoring devices like the Crit-line platform are included in the company's product pipeline. The company primarily operates in - The Health Care Services segment: Consists of the company's Dialysis Services and the Care-Coordination (non-dialysis laboratory services). The Health Care Products segment: Comprises of the company's Dialysis machines, dialyzers, dialysis solutions, hemodialysis concentrates, bloodline systems, water treatment systems, dialysis drugs and other medical products.. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $206.837B | 25.23 |
| Intuitive Surgical (ISRG) | United States | $191.293B | 100.01 |
| Alcon (ALC) | Switzerland | $42.858B | 28.68 |
| Edwards Lifesciences (EW) | United States | $38.815B | 24.65 |
| IQVIA Holdings (IQV) | United States | $38.763B | 21.36 |
| IDEXX Laboratories (IDXX) | United States | $34.892B | 41.09 |
| DexCom (DXCM) | United States | $29.037B | 43.73 |
| Waters (WAT) | United States | $22.907B | 33.87 |
| STERIS (STE) | Ireland | $21.985B | 25.31 |
| SONOVA HOLDING (SONVY) | Switzerland | $21.643B | 0.00 |
| Hologic (HOLX) | United States | $18.526B | 19.55 |
| Sysmex ADR (SSMXY) | Japan | $12.594B | 39.49 |
| Globus Medical (GMED) | United States | $11.296B | 28.77 |
| Teleflex (TFX) | United States | $9.083B | 14.49 |
| Penumbra (PEN) | United States | $9.066B | 88.81 |
| Masimo (MASI) | United States | $8.612B | 41.67 |
| Glaukos (GKOS) | United States | $7.919B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $4.986B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.592B | 26.02 |
| TransMedics (TMDX) | United States | $3.068B | 97.25 |
| Inari Medical (NARI) | United States | $3.003B | 0.00 |
| Veracyte (VCYT) | United States | $2.964B | 88.93 |
| LivaNova (LIVN) | United Kingdom | $2.878B | 16.61 |
| Nihon Kohden (NHNKY) | Japan | $2.557B | 19.42 |
| Elekta AB (EKTAY) | Sweden | $2.252B | 18.35 |
| Tandem Diabetes Care (TNDM) | United States | $2.043B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.914B | 10.00 |
| RxSight (RXST) | United States | $1.832B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.316B | 0.00 |
| Artivion (AORT) | United States | $1.162B | 77.03 |
| OPKO Health (OPK) | United States | $1.099B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.091B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.915B | 15.55 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.735B | 0.00 |
| IRadimed (IRMD) | United States | $0.722B | 39.01 |
| SiBone (SIBN) | United States | $0.652B | 0.00 |
| Paragon 28 (FNA) | United States | $0.627B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.610B | 14.39 |
| Pacific Biosciences Of California (PACB) | United States | $0.601B | 0.00 |
| AxoGen (AXGN) | United States | $0.584B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.582B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.501B | 0.00 |
| CVRx (CVRX) | United States | $0.383B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.383B | 25.71 |
| Tactile Systems Technology (TCMD) | United States | $0.378B | 20.45 |
| Delcath Systems (DCTH) | United States | $0.310B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.307B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.290B | 0.00 |
| Inogen (INGN) | United States | $0.249B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.215B | 0.00 |
| NeuroPace (NPCE) | United States | $0.208B | 0.00 |
| Accuray (ARAY) | United States | $0.192B | 0.00 |
| Nevro (NVRO) | United States | $0.189B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.189B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.157B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.136B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.117B | 17.44 |
| Spectral Diagnostics (EDTXF) | Canada | $0.114B | 0.00 |
| 908 Devices (MASS) | United States | $0.101B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.098B | 0.00 |
| LENSAR (LNSR) | United States | $0.082B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.077B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.077B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.073B | 0.00 |
| Hyperfine (HYPR) | United States | $0.068B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.066B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.061B | 0.00 |
| InspireMD (NSPR) | Israel | $0.059B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.054B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.054B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.049B | 0.00 |
| Envoy Medical (COCH) | United States | $0.041B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.034B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.032B | 0.00 |
| Precision Optics (POCI) | United States | $0.031B | 0.00 |
| DarioHealth (DRIO) | United States | $0.029B | 0.00 |
| Spectral AI (MDAI) | United States | $0.025B | 0.00 |
| Neuronetics (STIM) | United States | $0.021B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.019B | 0.00 | |
| Microbot Medical (MBOT) | United States | $0.017B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.017B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.017B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.013B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.012B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.011B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.010B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.002B | 0.00 |
| Tenon Medical (TNON) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |